'Value for money' requirement in treatment choices.
Zielinski
Christoph
C
D003362:Cost-Benefit Analysis; D003657:Decision Making; D016527:Drug Costs; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000628:therapy